Cargando…
Mucopolysaccharidosis I, II, and VI: Brief review and guidelines for treatment
Mucopolysaccharidoses (MPS) are rare genetic diseases caused by the deficiency of one of the lysosomal enzymes involved in the glycosaminoglycan (GAG) breakdown pathway. This metabolic block leads to the accumulation of GAG in various organs and tissues of the affected patients, resulting in a multi...
Ejemplares similares
-
Molecular characterization of phenylketonuria patients from the North Region of Brazil: State of Pará
por: Bonfim‐Freitas, Pedro E., et al.
Publicado: (2023) -
Enzyme replacement therapy for Mucopolysaccharidosis Type I among patients followed within the MPS Brazil Network
por: Dornelles, Alícia Dorneles, et al.
Publicado: (2014) -
Unrelated hematopoietic stem cell transplantation in the pediatric population: single institution experience
por: Marinho, Daniela Hespanha, et al.
Publicado: (2015) -
Population analysis of xenobiotic metabolizing genes in South Brazilian Euro and Afro-descendants
por: Maciel, Marcos Euzébio, et al.
Publicado: (2009) -
Factors associated with knowledge of the disease in people with type 2 diabetes mellitus
por: Rabelo Santana Amaral, Verônica, et al.
Publicado: (2021)